You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • S34 The effects of a novel formulation of inhaled cromolyn sodium (pa101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, controlled, phase 2 trial

Alerts

Article menu

Download PDFPDF

A troublesome cough: from diagnosis to treatment
S34 The effects of a novel formulation of inhaled cromolyn sodium (pa101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, controlled, phase 2 trial
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address